Insights into psoriasis and other inflammatory diseases from large-scale gene expression studies

Human Molecular Genetics

Volumn 10, Issue 17, 2001, Pages 1793-1805

  Bowcock, Anne M ^a,d   Shannon, William ^a   Du, Fenghe ^a   Duncan, Jill ^a   Cao, Kai ^b   Aftergut, Kent ^c   Catier, Jennifer ^c   Fernandez Vina, Marcelo A ^b   Menter, Alan ^c  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b GEORGETOWN UNIVERSITY   (United States)

^c BAYLOR UNIVERSITY MEDICAL CENTER   (United States)

^d WASHINGTON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HLA ANTIGEN CLASS 1;

AGE; ARTICLE; AUTOIMMUNE DISEASE; CAUCASIAN; CHROMOSOME 14Q; CHROMOSOME 17Q; CHROMOSOME 19Q; CHROMOSOME 1Q; CHROMOSOME 3Q; CHROMOSOME 4Q; CHRONIC DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; DNA MICROARRAY; ENVIRONMENT; FEMALE; GENDER; GENE CLUSTER; GENE EXPRESSION; GENE LOCUS; GENE MAPPING; GENETIC ANALYSIS; GENETIC PREDISPOSITION; GENETIC RISK; GENETIC TRANSCRIPTION; HUMAN; HUMAN TISSUE; INFLAMMATORY DISEASE; MALE; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PSORIASIS; RISK FACTOR; SKIN DISEASE;

EID: 0035880456     PISSN: 09646906     EISSN: None     Source Type: Journal    
DOI: 10.1093/hmg/10.17.1793     Document Type: Article

References (92)

1. The genetics of psoriasis: A complex disorder of the skin and immune system
2. Psoriasis in practice
3. Insights into the pathogenesis of psoriasis and psoriatic arthritis
4. Group A streptococcal antigen-specific T lymphocytes in guttate psoriatic lesions
5. Immunology of AIDS related to psoriasis
6. Distinct serum cytokines in AIDS-related skin diseases
7. Histocompatibility (HLA) antigens associated with psoriasis
8. Disturbance of HLA antigen frequency in psoriasis
9. HLA genes in familial psoriasis vulgaris (pv): Evidence for genetic heterogeneity
10. HLA region genes and immune activation in the pathogenesis of psoriasis
11. Linkage analysis of human leukocyte antigen (HLA) markers in familial psoriasis: Strong disequilibrium effects provide evidence for a major determinant in the HLA-B/-C region
12. Identification of a major susceptibility locus on chromosome 6p and evidence for further disease loci revealed by a two stage genome-wide search in psoriasis
13. Searching for psoriasis susceptibility genes in Italy: Genome scan and evidence for a new locus on chromosome 1
14. Gene for familial psoriasis susceptibility mapped to the distal end of human chromosome 17q
15. Evidence that a locus for familial psoriasis maps to chromosome 4q
16. Psoriasis susceptibility locus in chromosome region 3q21 identified in patients from southwest Sweden
17. Genomewide scan in german families reveals evidence for a novel psoriasis-susceptibility locus on chromosome 19p13
18. Evidence for interaction between psoriasis-susceptibility loci on chromosomes 6p21 and 1q21
19. Evidence for two psoriasis susceptibility loci (HLA and 17q) and two novel candidate regions (16q and 20p) by genome-wide scan
20. Identification of a novel psoriasis susceptibility locus at 1p and evidence of epistasis between PSORS1 and candidate loci
21. Genetic linkage of childhood atopic dermatitis to psoriasis susceptibility loci
22. New susceptibility locus for rheumatoid arthritis suggested by a genome-wide linkage study
23. A major susceptibility locus for atopic dermatitis maps to chromosome 3q21
24. Susceptibility to insulin-dependent diabetes mellitus maps to a locus (IDDM11) on human chromosome 14q24.3-q31
25. Mapping of a major susceptibility locus for Graves' disease (GD-1) to chromosome 14q31
26. Mapping of a susceptibility locus for Crohn's disease on chromosome 16
27. A genomewide screen in multiplex rheumatoid arthritis families suggests genetic overlap with other autoimmune diseases
28. Clustering of non-major histocompatibility complex susceptibility candidate loci in human autoimmune diseases
29. Zeroing in on tolerance
30. Inflammatory skin diseases, T cells, and immune surveillance
31. Epidermal HLA-DR and the enhancement of cutaneous reactivity to superantigenic toxins in psoriasis
32. Immunohistochemical study of the early histopathologic changes occurring in trauma-injured skin of psoriatic patients
33. Adhesion molecules and IL-1 costimulate T lymphocytes in the autologous MECLR in psoriasis
34. Decreased growth inhibition by recombinant gamma interferon is associated with increased production of transforming growth factor alpha in keratinocytes cultured from psoriatic lesions
35. Differential expression of transforming growth factor-alpha (TGF-alpha) and EGF receptor in transitional area of psoriatic epidermis
36. Transition from symptomless to lesional psoriatic skin
37. Finding Groups in Data: An Introduction to Cluster Analysis
38. Cluster analysis and display of genome-wide expression patterns
39. CD69, HLA-DR and the IL-2R identify persistently activated T cells in psoriasis vulgaris lesional skin: Blood and skin comparisons by flow cytometry
40. The immunologic and genetic basis of psoriasis
41. Intraepidermal lymphocytes in psoriatic lesions are activated GMP-17(TIA-1)+CD8+CD3+ CTLs as determined by phenotypic analysis
42. The pathophysiological role of cytokines in psoriasis
43. Increased expression of epidermal IL-8 receptor in psoriasis. Down-regulation by FK-506 in vitro
44. High density synthetic oligonucleotide arrays
45. TNF-alpha and serum induce SKALP/elafin gene expression in human keratinocytes by a p38 MAP kinase-dependent pathway
46. Serial analysis of gene expression in differentiated cultures of human epidermal keratinocytes
47. Identification of a new interferon-alpha-inducible gene (p27) on human chromosome 14q32 and its expression in breast carcinoma
48. Primary structures of two homologous subunits of PA28, a γ-interferon-inducible protein activator of the 20S proteasome
49. cDNA cloning and interferon γ down-regulation of proteosomal subunits X and Y
50. Constitutive and interferon-γ-induced expression of the human proteasome subunit multi-catalytic endopeptidase complex-like 1
51. Measurements of unsaturated vitamin B12-binding capacity and myeloperoxidase as indices of severity of acute inflammation in serial colonoscopy biopsy specimens from patients with inflammatory bowel disease
52. Plasma vitamin B12 binding proteins correlate with disease activity in patients with rheumatoid arthritis
53. Elevated serum transcobalamin levels in anaemia of rheumatoid arthritis: Correlation with disease activity but not with serum tumour necrosis factor α and interleukin 6
54. Vitamin B12 and transcobalamin in chronic myeloproliferative disorders
55. Identification of human epidermal differentiation complex (EDC)-encoded genes by subtractive hybridization of entire YACs to a gridded keratinocyte cDNA library
56. Human epidermal differentiation complex in a single 2.5 Mbp long continuum of overlapping DNA cloned in bacteria integrating physical and transcript maps
57. Fine mapping of the PSORS4 psoriasis susceptibility region on chromosome 1q21
58. Locus control regions coming of age at a decade plus
59. Ulcerative colitis and Crohn's disease: Distinctive gene expression profiles and novel susceptibility candidate genes
60. A high-density probe array sample preparation method using 10- to 100-fold fewer cells
61. Light-directed spatially addressable parallel chemical synthesis
62. Comparison of human adult and fetal expression and identification of 535 housekeeping/maintenance genes
63. Locus-specific amplification of HLA class I genes from genomic DNA: Locus specific sequences in the first and third introns of HLA-A, -B and -C
64. High and intermediate resolution DNA typing systems for class I HLA-A, -B, -C genes by hybridization with sequence-specific oligonucleotide probes (SSOP)
65. Assignment of psoriasin to human chromosomal band 1q21: Co-ordinate overexpression of clustered genes in psoriasis
66. Molecular cloning, occurrence, and expression of a novel partially secreted protein "psoriasin" that is highly up-regulated in psoriatic skin
67. Molecular cloning and expression of a novel keratinocyte protein (psoriasis-associated fatty acid-binding protein [PA-FABP]) that is highly up-regulated in psoriatic skin and that shares similarity to fatty acid-binding proteins
68. Expression of cornifin in squamous differentiating epithelial tissues, including psoriatic and retinoic acid-treated skin
69. Induction of normal and psoriatic phenotypes in submerged keratinocyte cultures
70. Human beta-defensin-2
71. Changes in keratin 6 and keratin 10 (co-)expression in lesional and symptomless skin of spreading psoriasis
72. Regulation of epidermal expression of keratin K17 in inflammatory skin diseases
73. Characterization of the human gene encoding cytokeratin 17 and its expression pattern
74. Up-regulation of keratin 17 expression in human HaCaT keratinocytes by interferon-gamma
75. Keratins (K16 and K17) as markers of keratinocyte hyperproliferation in psoriasis in vivo and in vitro
76. Identification of aberrantly regulated genes in diseased skin using the cDNA differential display technique
77. Precocious appearance of involucrin and epidermal transglutaminase during differentiation of psoriatic skin
78. Decreased beta 2-adrenergic receptor-mRNA and loricrin-mRNA, and increased involucrin-mRNA transcripts in psoriatic epidermis: Analysis by reverse transcription-polymerase chain reaction
79. Growth factor and proto-oncogene expression in psoriasis
80. Epidermis contains platelet-type 12-lipoxygenase that is overexpressed in germinal layer keratinocytes in psoriasis
81. Sequencing and expression analysis of the serine protease gene cluster located in chromosome 19q13 region
82. Aberrant production of interleukin-8 and thrombospondin-1 by psoriatic keratinocytes mediates angiogenesis
83. Expression of insulin-like growth factor binding protein-3 (IGFBP-3) in the psoriatic lesion
84. IL-1 beta and IFN-gamma induce the regenerative epidermal phenotype of psoriasis in the transwell skin organ culture system. IFN-gamma up-regulates the expression of keratin 17 and keratinocyte trans IL-1 production
85. Increased expression of interleukin-4 receptors on psoriatic epidermal cells
86. Increased numbers of CD68 antigen positive dendritic epidermal cells and upregulation of CLA (cutaneous lymphocyte-associated antigen) expression on these cells in various skin diseases
87. Localization of monocyte chemotactic and activating factor (MCAF/MCP-1) in psoriasis
88. Identificatioin of a tissue kallikrein in human polymorphonuclear leucocytes
89. Overexpression of the angiogenic factor platelet-derived endothelial cell growth factor thymidine phosphorylase in psoriatic epidermis
90. Keratin 15 expression in stratified epithelia: Downregulation in activated keratinocytes
91. C-fos and c-jun proto-oncogene expression is decreased in psoriasis: An in situ quantitative analysis
92. Model-based analysis of oligonucleotide arrays: Expression index Computation and outlier detection